Efficacy Study of Water Drinking on PKD Progression.

NCT01348035 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2018-03-15

No results posted yet for this study

Summary

This is a prospective 5-year study to compare the change in total kidney volume (TKV) before and after tolvaptan therapy, as the primary endpoint, in patients with ADPKD.

Conditions

  • Autosomal Dominant Polycystic Kidney Disease
  • Disease Progression

Sponsors & Collaborators

  • Kyorin University

    lead OTHER

Principal Investigators

  • Eiji Higashihara, M.D. · Kyorin University

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2012-11-30
Completion
2013-01-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01348035 on ClinicalTrials.gov